2006
DOI: 10.1186/1472-6963-6-143
|View full text |Cite
|
Sign up to set email alerts
|

Direct and indirect costs of Multiple Sclerosis in Baix Llobregat (Catalonia, Spain), according to disability

Abstract: Background: Multiple sclerosis (MS) is an incurable chronic disease that predominantly affects young adults. It has a high socio-economic impact which increases as disability progresses. An assessment of the real costs of MS may contribute to our knowledge of the disease and to treat it more efficiently. Our objective is to assess the direct and indirect costs of MS from a societal perspective, in patients monitored in our MS Unit (Baix Llobregat, Catalonia) and grouped according to their disability (EDSS).

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

4
29
0
13

Year Published

2011
2011
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 44 publications
(46 citation statements)
references
References 33 publications
4
29
0
13
Order By: Relevance
“…It has e.g., been argued that there might be contextual differences for patients with MS to rely on family members or on friends for informal care, which can also affect the calculated cost for informal care [51]. As the included studies categorized informal care as an unspecified direct cost [27,34,35,52,53], as a direct nonmedical cost [37][38][39][40][41][42][43][44][45][46][47][48][49][50][51]53], presented separately from direct and indirect costs [58] or, as an indirect cost [26,57], Included cost categories, as well as e.g., proportions will differ due to methodological choices.…”
Section: Methods Of Calculation Affects the Comparability Between Stumentioning
confidence: 99%
“…It has e.g., been argued that there might be contextual differences for patients with MS to rely on family members or on friends for informal care, which can also affect the calculated cost for informal care [51]. As the included studies categorized informal care as an unspecified direct cost [27,34,35,52,53], as a direct nonmedical cost [37][38][39][40][41][42][43][44][45][46][47][48][49][50][51]53], presented separately from direct and indirect costs [58] or, as an indirect cost [26,57], Included cost categories, as well as e.g., proportions will differ due to methodological choices.…”
Section: Methods Of Calculation Affects the Comparability Between Stumentioning
confidence: 99%
“…3 In multiple sclerosis (MS), a number of studies have been published, including cost of illness assessments. [4][5][6][7] The availability of disease-modifying treatments (DMTs) has led to changes in patient management and to focus on earlier and better diagnosis and adjustments in the diagnostic criteria themselves. One of the consequences in this regard is that the recorded prevalence of the disease is quite different from that estimated two or three decades ago.…”
Section: Introductionmentioning
confidence: 99%
“…So far, social costs have been estimated using micro data with reference to specific illnesses (Amato et al, 2002;Patti et al, 2011;Leardini et al, 2002;Casado et al, 2006;Kobelt, 2006;Kobelt et al, 2006a;Kobelt et al, 2006b;Russo et al, 2004;Naci et al, 2010). As far as we know, macro data allowing a quantification of disability costs are not available.…”
Section: Social Costs Computationmentioning
confidence: 99%
“…In the costs of diseases analysis, evaluations of costs associated to illness are defined as social cost studies (Montanelli and Gerzeli, 2001;Amato et al, 2002;Patti et al, 2011;Leardini et al, 2002;Casado et al, 2006;Kobelt et al, 2004;Kobelt, 2006;Kobelt et al, 2006a;Kobelt et al, 2006b;Russo et al, 2004;Naci et al, 2010) 6 .…”
Section: Social Costs Computationmentioning
confidence: 99%